ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Proteostasis Therapeutics, Inc." (PTI) Report Updated: Jun 24, 2017 | Print This Page

Get more stock ratings by Louis Navellier

"Proteostasis Therapeutics, Inc." (PTI)

Rating: Strong Sell Volatility: Aggressive
Total Grade: F Industry: Biotechnology
Competitors: RGEN,EXEL,CLVS,VRTX

Stock Analysis

Rating: Monthly View

A
B
C
D
F
June July August September October November December January February March April May

Rating: Weekly View

This Week: F down no change
Last Week: F same no change
Two Weeks Ago: F up downgrade
service keys

"Proteostasis Therapeutics, Inc."© quotemedia

Company Profile